For people with Crohn's disease, the question "What should I eat?" often goes unanswered. Doctors know the condition causes inflammation in the digestive tract—triggering pain, diarrhea, cramping, weight loss—but dietary guidance has been frustratingly sparse. Now a Stanford Medicine trial offers something concrete: a brief, calorie-restricted eating plan that measurably eases symptoms and reduces the biological markers of disease.
The study, published in Nature Medicine, followed 97 people with mild-to-moderate Crohn's over three months. Those in the fasting mimicking group (65 participants) sharply cut calories for five consecutive days each month—consuming roughly 700 to 1,100 calories daily on plant-based meals—then ate normally the rest of the time. The control group (32 participants) continued their usual diet. The results were clear: the fasting group saw significant improvements in both how they felt and what their blood and stool markers revealed.
Why this matters becomes clearer when you consider the current options. Crohn's affects about a million Americans, and for mild cases, steroids remain the only approved treatment. But long-term steroid use carries serious side effects, leaving patients and doctors searching for alternatives. A dietary approach with no medication side effects—one that actually works—fills a real gap.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxWhat the biology showed
The researchers didn't just ask participants how they felt. They measured fecal calprotectin, a protein in stool that signals gut inflammation, and found it dropped significantly in the fasting group compared to controls. They also tracked inflammatory molecules in blood and immune cell responses. In people who fasted, several types of inflammation-promoting molecules declined, and immune cells produced fewer inflammatory signals overall.
This isn't magic—it's biology. The fasting period appears to trigger a reset in how the gut and immune system interact, reducing the inflammatory cascade that defines Crohn's disease. Dr. Sinha, who led the research, notes the mechanism still needs deeper exploration. "There's still a lot more to be done to understand the biology behind how this and other diets work," he said.
What comes next is the real question: whether this approach works for moderate-to-severe cases, whether people can sustain it long-term, and how it might combine with other treatments. But for now, this trial gives doctors and patients a research-backed answer to a question that's gone unanswered for too long.
